ZIVO Bioscience, Inc. (ZIVO)

USD 16.02

(-15.68%)

Long Term Debt Summary of ZIVO Bioscience, Inc.

  • ZIVO Bioscience, Inc.'s latest annual long term debt in 2023 was - USD , down -100.0% from previous year.
  • ZIVO Bioscience, Inc.'s latest quarterly long term debt in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • ZIVO Bioscience, Inc. reported annual long term debt of 105.91 Thousand USD in 2022, down 0.0% from previous year.
  • ZIVO Bioscience, Inc. reported annual long term debt of - USD in 2021, down -100.0% from previous year.
  • ZIVO Bioscience, Inc. reported quarterly long term debt of - USD for 2024 Q2, down 0.0% from previous quarter.
  • ZIVO Bioscience, Inc. reported quarterly long term debt of 50.92 Thousand USD for 2023 Q2, down -35.57% from previous quarter.

Annual Long Term Debt Chart of ZIVO Bioscience, Inc. (2023 - 2000)

Historical Annual Long Term Debt of ZIVO Bioscience, Inc. (2023 - 2000)

Year Long Term Debt Long Term Debt Growth
2023 - USD -100.0%
2022 105.91 Thousand USD 0.0%
2021 - USD -100.0%
2020 136.87 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD -100.0%
2017 15.95 Million USD 402.32%
2016 3.17 Million USD -30.94%
2015 4.59 Million USD 1840.06%
2014 237.04 Thousand USD -73.39%
2013 890.81 Thousand USD 49.99%
2012 593.9 Thousand USD 40.27%
2011 423.39 Thousand USD 306.86%
2010 104.06 Thousand USD -59.1%
2009 254.43 Thousand USD 77.75%
2008 143.14 Thousand USD -46.82%
2007 269.19 Thousand USD 1058.27%
2006 23.24 Thousand USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%

Peer Long Term Debt Comparison of ZIVO Bioscience, Inc.

Name Long Term Debt Long Term Debt Difference
America Great Health 1.12 Million USD 100.0%
Ampio Pharmaceuticals, Inc. - USD NaN%
Aridis Pharmaceuticals, Inc. 1.29 Million USD 100.0%
Biora Therapeutics, Inc. 43.73 Million USD 100.0%
Bio-Path Holdings, Inc. 10 Thousand USD 100.0%
Better Therapeutics, Inc. 10.34 Million USD 100.0%
Calithera Biosciences, Inc. 136 Thousand USD 100.0%
Comera Life Sciences Holdings, Inc. 120.3 Thousand USD 100.0%
Gene Biotherapeutics, Inc. - USD NaN%
eFFECTOR Therapeutics, Inc. - USD NaN%
Eloxx Pharmaceuticals, Inc. 8.69 Million USD 100.0%
Evelo Biosciences, Inc. 48.87 Million USD 100.0%
Evolutionary Genomics, Inc. 3.74 Million USD 100.0%
Finch Therapeutics Group, Inc. 28.4 Million USD 100.0%
Galera Therapeutics, Inc. 151.04 Million USD 100.0%
Innovation1 Biotech Inc. 218.99 Thousand USD 100.0%
Kiromic BioPharma, Inc. 911.5 Thousand USD 100.0%
Molecular Templates, Inc. 9.74 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD 100.0%
NexImmune, Inc. - USD NaN%
Orgenesis Inc. 19.06 Million USD 100.0%
Panbela Therapeutics, Inc. 4.19 Million USD 100.0%
Point of Care Nano-Technology, Inc. - USD NaN%
PaxMedica, Inc. Common Stock - USD NaN%
Scopus BioPharma Inc. - USD NaN%
Sorrento Therapeutics, Inc. 104.33 Million USD 100.0%
Statera Biopharma, Inc. 11.43 Million USD 100.0%
TRACON Pharmaceuticals, Inc. 732 Thousand USD 100.0%
Trevena, Inc. 35.23 Million USD 100.0%
Vaxxinity, Inc. 13.26 Million USD 100.0%
Vaccinex, Inc. 26 Thousand USD 100.0%
Vicapsys Life Sciences, Inc. - USD NaN%
Viracta Therapeutics, Inc. - USD NaN%